Lyra Therapeutics, INC. (LYRA) SEC Filings — 2025
16 SEC filings for Lyra Therapeutics, INC. (LYRA) in 2025.
Filings
- Lyra's Losses Narrow Amidst R&D Cuts, Going Concern Doubts Persist — 10-Q · Nov 12, 2025
- Lyra Therapeutics Files 8-K — 8-K · Sep 4, 2025
- Lyra Therapeutics Faces Nasdaq Delisting Warning — 8-K · Aug 22, 2025
- Lyra Therapeutics Navigates Restructuring Amidst Zero Revenue — 10-Q · Aug 12, 2025
- Lyra Therapeutics Director Departs, Officer Compensation Noted — 8-K · Aug 1, 2025
- Lyra Therapeutics Files S-1 for Continuous Offering, Signaling Capital Raise — S-1 · Jul 22, 2025
- Lyra Therapeutics Announces Material Definitive Agreement — 8-K · Jun 27, 2025
- Lyra Therapeutics Merges with HealthBeacon Subsidiary, Delists from Nasdaq — 8-K · Jun 23, 2025
- Lyra Therapeutics Files 8-K — 8-K · Jun 9, 2025
- Lyra Therapeutics Files 8-K with Corporate Updates — 8-K · Jun 2, 2025
- AtriCure to Acquire Lyra Therapeutics for $1.1B — 8-K · May 19, 2025
- Lyra Therapeutics Files Proxy Materials — DEFA14A · May 9, 2025
- Lyra Therapeutics Files Q1 2025 10-Q — 10-Q · May 6, 2025
- Lyra Therapeutics Files Definitive Proxy Statement — DEF 14A · Apr 4, 2025
- Lyra Therapeutics Files 2024 10-K — 10-K · Mar 13, 2025
- Lyra Therapeutics Files 8-K — 8-K · Jan 10, 2025